课题基金 / 基金详情

Otitis media in Indigenous and non-Indigenous children: microbiological and immunological risk factors

Otitis media in Indigenous and non-Indigenous children: microbiological and immunological risk factors
土著和非土著儿童的中耳炎:微生物学和免疫学危险因素
批准号:
nhmrc : 212044
负责人:
A/Pr Deborah Lehmann
金额:
$35.63万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2002
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2002-01-01 至 2004-12-31

项目摘要

项目成果

A/Pr Deborah Lehmann的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Otitis media (middle ear infections) is a major health problem in children. Many children suffer repeated attacks requiring frequent courses of antibiotics, some need surgery and some suffer serious consequences, particularly hearing loss. This can affect performance at school, hence employment and social circumstances in adulthood. Indigenous children suffer much higher rates of disease with more complications than non-Indigenous children. Many factors predispose to the heavy burden of disease. In the Kalgoorlie-Boulder area we are following Indigenous and non-Indigenous children from birth to 24 months to look at a broad range of factors in order to proceed as soon as possible to appropriate intervention programs. Samples from the back of the nose are collected to find out the relationship between carriage of a range of bacteria or viruses and risk of getting otitis media. Information on antibiotic resistance of the bacteria we isolate will assist in ensuring appropriate treatment of otitis media. We also collect a sample of breast milk from mothers and several samples of saliva to find out about the immune system of babies and how this relates to disease to assist in an ongoing program of vaccine development for prevention of otitis media. We will find out how environmental factors such as crowding or passive smoking relate to carriage of bacteria and whether a combination of different factors increase risk of disease. A new vaccine called pneumococcal conjugate vaccine, recently licensed in Australia, is highly effective in preventing severe diseases such as pneumonia and meningitis and affords some protection against ear infections. It is likely to be offered first to Indigenous children because they suffer very high rates of pneumococcal disease. The vaccine may alter the types of bacteria in the nose. This needs to be monitored carefully which will be possible during this study.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Comparing pneumococcal vaccines in a high risk population: a randomised controlled trial of immunogenicity, safety and impact on carriage of pneumococcal conjugate and polysaccharide vaccines in infants in Papua New Guinea
  • 批准号:
    nhmrc : GNT1087200
  • 项目类别:
    Project Grants
  • 资助金额:
    $100.96万
  • 财政年份:
    2015
  • 负责人:
    A/Pr Deborah Lehmann
  • 依托单位:
国内基金
海外基金
Th1/Th2细胞失衡模式在分泌性中耳炎发病机制中作用的研究
  • 批准号:
    81070777
  • 项目类别:
    面上项目
  • 资助金额:
    32.0万元
  • 批准年份:
    2010
  • 负责人:
    赵守琴
  • 依托单位:
心脏超声造影的安全性研究
  • 批准号:
    30870721
  • 项目类别:
    面上项目
  • 资助金额:
    31.0万元
  • 批准年份:
    2008
  • 负责人:
    查道刚
  • 依托单位:
声学造影技术在炎症诊断中的应用基础研究
  • 批准号:
    30370589
  • 项目类别:
    面上项目
  • 资助金额:
    18.0万元
  • 批准年份:
    2003
  • 负责人:
    查道刚
  • 依托单位: